NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Nutanix Q1 Earnings: Meets EPS But Cuts Revenue Guidance

Nutanix (NTNX) reports 18% ARR growth and $174.5M free cash flow in Q1 FY2026, but significantly lowers Q2 and full-year revenue guidance below estimates.

Nutanix Q1 Earnings: Meets EPS But Cuts Revenue Guidance
Credit: Andrey Rudakov/Bloomberg
Already have an account? Sign in.
11/25/2025 · 5:05 PM
NTNX
/ Don’t stop at just one post.

Related↓

Nutanix Beats Q2 Expectations + Lands $250M AMD Investment
Featured/ 02/25/2026 · 6:22 PM

Nutanix Beats Q2 Expectations + Lands $250M AMD Investment

AMD is partnering with Nutanix, investing $150 million in equity and $100 million in cash to develop easy-to-use AI platforms. Nutanix also beat Q2 earnings expectations, reporting 10% revenue growth.

/ Subscriber only
/ Read more

Feed↓

Novartis, Ionis Heart Drug Misses Phase 3 Goal Despite Cutting Lp(a)
Featured/ 09/04/2026 · 5:21 PM

Novartis, Ionis Heart Drug Misses Phase 3 Goal Despite Cutting Lp(a)

Novartis and Ionis said pelacarsen lowered Lp(a) but failed to cut heart attacks, strokes or deaths in a Phase 3 trial of 8,323 patients.

/ Subscriber only
Canaccord Initiates Belite Bio at Buy With $303 Target on Stargardt Therapy
09/04/2026 · 11:46 AM

Canaccord Initiates Belite Bio at Buy With $303 Target on Stargardt Therapy

Canaccord cites tinlarebant as the first drug shown to slow Stargardt lesion growth. The PDUFA date is February 12, 2027.

/ Subscriber only
AMC CEO Blasts Robinhood Over Tokenized Shares, Threatens SEC Action
09/04/2026 · 11:16 AM

AMC CEO Blasts Robinhood Over Tokenized Shares, Threatens SEC Action

AMC CEO Adam Aron calls Robinhood’s AMC stock tokens vile and a fake market, demands a halt, and considers an SEC complaint.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe